DE69121844D1 - Immunotest für Cyclosporin - Google Patents
Immunotest für CyclosporinInfo
- Publication number
- DE69121844D1 DE69121844D1 DE69121844T DE69121844T DE69121844D1 DE 69121844 D1 DE69121844 D1 DE 69121844D1 DE 69121844 T DE69121844 T DE 69121844T DE 69121844 T DE69121844 T DE 69121844T DE 69121844 D1 DE69121844 D1 DE 69121844D1
- Authority
- DE
- Germany
- Prior art keywords
- cyclosporin
- conjugated
- conjugates
- label
- disclosed
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/5306—Improving reaction conditions, e.g. reduction of non-specific binding, promotion of specific binding
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/44—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material not provided for elsewhere, e.g. haptens, metals, DNA, RNA, amino acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/64—Cyclic peptides containing only normal peptide links
- C07K7/645—Cyclosporins; Related peptides
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/531—Production of immunochemical test materials
- G01N33/532—Production of labelled immunochemicals
- G01N33/535—Production of labelled immunochemicals with enzyme label or co-enzymes, co-factors, enzyme inhibitors or enzyme substrates
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/94—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving narcotics or drugs or pharmaceuticals, neurotransmitters or associated receptors
- G01N33/9493—Immunosupressants
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S435/00—Chemistry: molecular biology and microbiology
- Y10S435/962—Prevention or removal of interfering materials or reactants or other treatment to enhance results, e.g. determining or preventing nonspecific binding
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S436/00—Chemistry: analytical and immunological testing
- Y10S436/815—Test for named compound or class of compounds
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S436/00—Chemistry: analytical and immunological testing
- Y10S436/825—Pretreatment for removal of interfering factors from sample
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S436/00—Chemistry: analytical and immunological testing
- Y10S436/829—Liposomes, e.g. encapsulation
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
- Y10S530/807—Hapten conjugated with peptide or protein
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Biomedical Technology (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Organic Chemistry (AREA)
- Food Science & Technology (AREA)
- Analytical Chemistry (AREA)
- Biotechnology (AREA)
- Cell Biology (AREA)
- Pathology (AREA)
- Microbiology (AREA)
- General Physics & Mathematics (AREA)
- Physics & Mathematics (AREA)
- Genetics & Genomics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biophysics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Peptides Or Proteins (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US61611690A | 1990-11-20 | 1990-11-20 |
Publications (2)
Publication Number | Publication Date |
---|---|
DE69121844D1 true DE69121844D1 (de) | 1996-10-10 |
DE69121844T2 DE69121844T2 (de) | 1997-01-23 |
Family
ID=24468093
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE69133095T Expired - Lifetime DE69133095T2 (de) | 1990-11-20 | 1991-11-19 | Cyclosporin-Immunoassay |
DE69121844T Expired - Lifetime DE69121844T2 (de) | 1990-11-20 | 1991-11-19 | Immunotest für Cyclosporin |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE69133095T Expired - Lifetime DE69133095T2 (de) | 1990-11-20 | 1991-11-19 | Cyclosporin-Immunoassay |
Country Status (7)
Country | Link |
---|---|
US (3) | US6190873B1 (de) |
EP (2) | EP0674178B1 (de) |
JP (2) | JP3433952B2 (de) |
AT (1) | ATE142344T1 (de) |
CA (1) | CA2055813A1 (de) |
DE (2) | DE69133095T2 (de) |
ES (2) | ES2091301T3 (de) |
Families Citing this family (49)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7279561B1 (en) | 1993-04-23 | 2007-10-09 | Wyeth | Anti-rapamycin monoclonal antibodies |
ES2176245T3 (es) | 1993-04-23 | 2002-12-01 | Wyeth Corp | Anticuerpos de ramapicinas de ciclo abierto. |
WO1996040662A2 (en) * | 1995-06-07 | 1996-12-19 | Cellpro, Incorporated | Aminooxy-containing linker compounds and their application in conjugates |
US5650288A (en) * | 1995-07-14 | 1997-07-22 | Macfarlane; Gordon D. | Immunophilin-bound immunosuppressant assay |
EP1719781A3 (de) * | 1997-08-08 | 2006-11-15 | Dade Behring Marburg GmbH | Verfahren zum Einbringen einer aminreaktiven Gruppe in einem Dextran |
US6007992A (en) * | 1997-11-10 | 1999-12-28 | Gilead Sciences, Inc. | Pyrimidine derivatives for labeled binding partners |
US6028183A (en) | 1997-11-07 | 2000-02-22 | Gilead Sciences, Inc. | Pyrimidine derivatives and oligonucleotides containing same |
US5990274A (en) | 1997-11-25 | 1999-11-23 | Dade Behring Inc. | Cyclosporine derivatives and uses thereof |
US6231982B1 (en) | 1997-12-10 | 2001-05-15 | Dade Behring Inc. | Particle reagents having reduced matrix effects and containing an aldehyde-reactive functional group |
US6686454B1 (en) | 1998-10-09 | 2004-02-03 | Isotechnika, Inc. | Antibodies to specific regions of cyclosporine related compounds |
BR9914092A (pt) | 1998-10-09 | 2001-06-12 | Isotechnika Inc | Processos para a produção de anticorpos a regiões especìficas de ciclosporina e metabólitos de ciclosporina |
KR20020039528A (ko) * | 2000-11-22 | 2002-05-27 | 조명재 | 사이클로스포린 7- 티오아미드 유도체를 유효성분으로하는 모발성장촉진제 |
US7045098B2 (en) | 2001-02-02 | 2006-05-16 | James Matthew Stephens | Apparatus and method for removing interfering substances from a urine sample using a chemical oxidant |
PL210841B1 (pl) | 2001-10-19 | 2012-03-30 | Isotechnika Inc | Sposób wytwarzania mieszaniny izomerów (E) i (Z) ISATX247 |
US20030109067A1 (en) * | 2001-12-06 | 2003-06-12 | Immunetech, Inc. | Homogeneous immunoassays for multiple allergens |
US20030022390A1 (en) * | 2002-05-30 | 2003-01-30 | Stephens James Matthew | Method and kit for making interfering substances in urine undetectable |
EP1582870B1 (de) * | 2002-12-26 | 2011-03-16 | Nitto Boseki Co., Ltd. | Immunoassay-verfahren |
US20080188479A1 (en) * | 2004-05-30 | 2008-08-07 | Sloan-Kettering Institute For Cancer Research | Methods to Treat Cancer with 10-propargyl-10-deazaaminopterin and Methods for Assessing Cancer for Increased Sensitivity to 10-propargyl-10-deazaaminopterin |
US8263354B2 (en) * | 2004-05-30 | 2012-09-11 | Sloan-Kettering Institute For Cancer Research | Methods for assessing cancer for increased sensitivity to 10-propargyl-10-deazaaminopterin |
DE602005009176D1 (de) * | 2004-05-30 | 2008-10-02 | Sloan Kettering Inst Cancer | Behandlung von t-zellen-lymphom mittels 10-propargyl-10-deazaaminopterin |
US7226906B2 (en) * | 2004-08-16 | 2007-06-05 | Array Biopharma, Inc. | Cyclosporin analogs for the treatment of immunoregulatory disorders and respiratory diseases |
US8021849B2 (en) * | 2004-11-05 | 2011-09-20 | Siemens Healthcare Diagnostics Inc. | Methods and kits for the determination of sirolimus in a sample |
US20060216762A1 (en) * | 2005-03-24 | 2006-09-28 | Bayer Healthcare Llc | Extracting reagent for hydrophobic analyte in whole blood |
US7189582B2 (en) * | 2005-04-27 | 2007-03-13 | Dade Behring Inc. | Compositions and methods for detection of sirolimus |
WO2008121096A1 (en) * | 2005-05-19 | 2008-10-09 | The Board Of Governors For Higher Education | Monitoring cyclosporine in saliva |
BRPI0706575B8 (pt) * | 2006-01-13 | 2021-05-25 | Univ Indiana Res & Tech Corp | uso colágeno de tipo v ou um componente antigênico do mesmo, e, método para identificar um paciente em espera de transplante de pulmão para um risco aumentado de rejeição de tecido de órgão transplantado. |
US20080081379A1 (en) * | 2006-07-13 | 2008-04-03 | Sigler Gerald F | Homogeneous double receptor agglutination assay for immunosuppressant drugs |
US7883855B2 (en) | 2006-07-21 | 2011-02-08 | Abbott Laboratories | Immunosuppressant drug extraction reagent for immunoassays |
US7914999B2 (en) * | 2006-12-29 | 2011-03-29 | Abbott Laboratories | Non-denaturing lysis reagent |
ES2393135T3 (es) * | 2006-12-29 | 2012-12-18 | Abbott Laboratories | Ensayo mejorado para fármacos inmunosupresores |
JP5450092B2 (ja) | 2006-12-29 | 2014-03-26 | アボット・ラボラトリーズ | 全血中の分子または薬物の検出のための診断検査 |
EP2118657B1 (de) * | 2006-12-29 | 2014-05-21 | Abbott Laboratories | Nichtdenaturierendes lysereagens zur verwendung mit einem capture-in-solution-immunoassay |
CA2685830C (en) * | 2007-05-24 | 2012-12-18 | Abbott Laboratories | Immunoassays exhibiting reduced cross-reactivity with hydrophobic drug analyte metabolites |
US7790401B2 (en) * | 2007-08-06 | 2010-09-07 | Siemens Healthcare Diagnostics | Methods for detection of immunosuppressant drugs |
US20100248249A1 (en) * | 2007-08-17 | 2010-09-30 | Allos Therapeutics, Inc. | Methods for Assessing Cancer for Increased Sensitivity to 10-Propargyl-10-Deazaaminopterin by Assessing Egfr Levels |
US20090048262A1 (en) * | 2007-08-17 | 2009-02-19 | Allos Therapeutics, Inc. | Combination of 10-propargyl-10-deazaaminopterin and erlotinib for the treatment of non-small cell lung cancer |
US9901578B2 (en) | 2007-08-17 | 2018-02-27 | Allos Therapeutics, Inc. | Combination of 10-propargyl-10-deazaaminopterin and erlotinib for the treatment of non-small cell lung cancer |
US7910378B2 (en) * | 2007-12-14 | 2011-03-22 | Siemens Healthcare Diagnostics Inc. | Methods for detection of hydrophobic drugs |
US20090170218A1 (en) * | 2008-01-02 | 2009-07-02 | Dade Behring Inc. | Methods for detection of cyclosporin a |
EP2277040A4 (de) * | 2008-04-21 | 2011-06-08 | Univ Arkansas | Vorrichtung und verfahren für paracetamol-proteinaddukttest |
DK2531193T3 (en) | 2010-02-02 | 2016-11-07 | Allos Therapeutics Inc | Diastereomers of the 10-propargyl-10-deazaaminopterin FOR USE IN THE TREATMENT OF CANCER |
CN102368072B (zh) * | 2011-06-30 | 2014-09-24 | 同昕生物技术(北京)有限公司 | 检测环孢霉素a药物浓度的化学发光酶联免疫检测试剂盒 |
CN104603146B (zh) | 2012-09-29 | 2018-01-02 | 诺华股份有限公司 | 环肽类化合物及其作为药物的用途 |
US8883857B2 (en) | 2012-12-07 | 2014-11-11 | Baylor College Of Medicine | Small molecule xanthine oxidase inhibitors and methods of use |
EP3104849B1 (de) | 2014-02-14 | 2019-08-28 | BioVentures, LLC | Acetaminophenproteinaddukte und verfahren zur verwendung davon |
AU2015358373B2 (en) | 2014-12-03 | 2021-05-27 | Arkansas Children's Research Institute | Anti-acetaminophen antibodies and acetaminophen protein adducts |
CN108794621A (zh) * | 2017-05-04 | 2018-11-13 | 南开大学 | 环孢霉素的偶联物及其制备方法与应用 |
CN110736835B (zh) * | 2018-07-19 | 2023-05-23 | 上海云泽生物科技有限公司 | 一种高灵敏度胶乳增强免疫比浊法测定全血中免疫抑制剂环孢霉素a的试剂盒 |
CN110174363A (zh) * | 2019-01-09 | 2019-08-27 | 北京九强生物技术股份有限公司 | 6-磷酸葡萄糖脱氢酶突变体及其在制备检测试剂中的用途 |
Family Cites Families (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4117118A (en) * | 1976-04-09 | 1978-09-26 | Sandoz Ltd. | Organic compounds |
US4396542A (en) | 1980-02-14 | 1983-08-02 | Sandoz Ltd. | Method for the total synthesis of cyclosporins, novel cyclosporins and novel intermediates and methods for their production |
IL62965A0 (en) | 1980-07-17 | 1981-07-31 | Scripps Miles Lab Inc | Monoclonal antibodies to drugs and theri production |
EP0056782B1 (de) * | 1981-01-09 | 1984-08-01 | Sandoz Ag | Cyclosporine |
CH667274A5 (de) * | 1984-03-23 | 1988-09-30 | Sandoz Ag | Cyclosporine, ihre herstellung und diese enthaltende pharmazeutische zusammensetzungen. |
US5169773A (en) * | 1984-10-04 | 1992-12-08 | Sandoz Ltd. | Monoclonal antibodies to cyclosporins |
WO1986002080A1 (en) * | 1984-10-04 | 1986-04-10 | Sandoz Ag | Monoclonal antibodies to cyclosporings |
US4727035A (en) * | 1984-11-14 | 1988-02-23 | Mahoney Walter C | Immunoassay for cyclosporin |
US4764503A (en) * | 1986-11-19 | 1988-08-16 | Sandoz Ltd. | Novel cyclosporins |
EP0283801A3 (de) * | 1987-03-27 | 1990-05-30 | Abbott Laboratories | Fluoreszenz-Polarisations-Test für Cyclosporin A und Metaboliten und verwandte Immunogene und Antikörper |
EP0373260B1 (de) * | 1987-06-22 | 1994-03-09 | Merck & Co. Inc. | Cyclosporin-Derivate, die eine modifizierte Aminosäure auf Stellung 8 tragen |
US5089390A (en) | 1987-09-04 | 1992-02-18 | Syntex (U.S.A.) Inc. | 2-methyl-4-hexene- and 2-methyl-4-heptene-1,2-diol derivatives |
CA1340387C (en) * | 1987-10-30 | 1999-02-09 | Carol A. Schlesinger | Heterobifunctional coupling agents |
CA2004626A1 (en) * | 1988-12-05 | 1990-06-05 | Bernard F. Erlanger | Derivatives of cyclosporine a, antibodies directed thereto and uses thereof |
DE69116034T2 (de) * | 1990-08-15 | 1996-06-20 | Abbott Lab | Immunotestreagenzien und Verfahren zur Bestimmung von Cyclosporin |
DK0487301T3 (da) * | 1990-11-20 | 2000-09-18 | Dade Behring Marburg Gmbh | Fremgangsmåde til stabilisering af enzymkonjugater |
-
1991
- 1991-11-19 ES ES91310632T patent/ES2091301T3/es not_active Expired - Lifetime
- 1991-11-19 DE DE69133095T patent/DE69133095T2/de not_active Expired - Lifetime
- 1991-11-19 EP EP95108148A patent/EP0674178B1/de not_active Expired - Lifetime
- 1991-11-19 EP EP91310632A patent/EP0487289B1/de not_active Expired - Lifetime
- 1991-11-19 AT AT91310632T patent/ATE142344T1/de not_active IP Right Cessation
- 1991-11-19 DE DE69121844T patent/DE69121844T2/de not_active Expired - Lifetime
- 1991-11-19 CA CA002055813A patent/CA2055813A1/en not_active Abandoned
- 1991-11-19 ES ES95108148T patent/ES2181734T3/es not_active Expired - Lifetime
- 1991-11-20 JP JP35424291A patent/JP3433952B2/ja not_active Expired - Lifetime
-
1995
- 1995-03-10 US US08/402,296 patent/US6190873B1/en not_active Expired - Lifetime
- 1995-03-10 US US08/401,827 patent/US6054303A/en not_active Expired - Lifetime
-
2000
- 2000-11-13 US US09/710,349 patent/US6410696B1/en not_active Expired - Lifetime
-
2002
- 2002-12-18 JP JP2002366051A patent/JP3936285B2/ja not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
EP0674178A3 (de) | 1996-07-10 |
DE69133095D1 (de) | 2002-10-02 |
ATE142344T1 (de) | 1996-09-15 |
JP3433952B2 (ja) | 2003-08-04 |
ES2091301T3 (es) | 1996-11-01 |
US6054303A (en) | 2000-04-25 |
JP2003201298A (ja) | 2003-07-18 |
JPH04316599A (ja) | 1992-11-06 |
DE69121844T2 (de) | 1997-01-23 |
JP3936285B2 (ja) | 2007-06-27 |
DE69133095T2 (de) | 2003-03-27 |
ES2181734T3 (es) | 2003-03-01 |
EP0487289B1 (de) | 1996-09-04 |
CA2055813A1 (en) | 1992-05-21 |
US6410696B1 (en) | 2002-06-25 |
EP0487289A2 (de) | 1992-05-27 |
EP0674178B1 (de) | 2002-08-28 |
EP0674178A2 (de) | 1995-09-27 |
EP0487289A3 (de) | 1994-02-23 |
US6190873B1 (en) | 2001-02-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE69121844T2 (de) | Immunotest für Cyclosporin | |
KR960702003A (ko) | 라파마이신 분석법(rapamycin assay) | |
DK261386A (da) | Monoklonale antistoffer | |
FI914298A0 (fi) | Monoklonala motkroppar foer metall- katjoner och smao molekyler. | |
FI913560A0 (fi) | Syntetiska peptider, speciellt foer observation av hcv-anti-kroppar, hcv-infektionsdiagnos och dess foerhindrande sm vaccin. | |
ES2063098T3 (es) | Nuevos derivados de digoxigenina y su utilizacion. | |
DE3886265T2 (de) | Anti-FR-900506-Stoffe-Antikörper und höchstempfindliches Enzym-Immunoassay-Verfahren. | |
EP0375422A3 (de) | Zusammensetzung und Methoden zur Bestimmung der Anwesenheit von Amphetaminen in einer Probe, die in Verdacht steht, Amphetamine und/oder Metamphetamine zu enthalten | |
EP0231914A3 (en) | Htlv-iii envelope peptides | |
DE69022578D1 (de) | Test für Hepatitis-C. | |
DE69610716T2 (de) | Topiramate-immunoassay, sowie analoge und antikörper | |
DE69609108D1 (de) | Verbesserte Immunoessayreagenzien zum Nachweis von Kannabinoiden | |
DK304087A (da) | Humant monoklonalt antistof mod lumfadenopati-associeret virus | |
ES2176347T3 (es) | Modulacion de la respuesta inmune. | |
ATE74662T1 (de) | Immunoanalysetestverfahren fuer cholesterolepoxide. | |
SE8103198L (sv) | Forfarande for framstellning av antikroppar | |
KR930703290A (ko) | 코티닌 면역검정용 합텐, 트레이서, 면역원 및 항체 | |
ATE88901T1 (de) | Fluorkohlenstoffkette enthaltende antigene konjugate. | |
ATE52251T1 (de) | Histamin-derivate, immunogen-konjugate und dadurch induzierte antikoerper. | |
AU6873487A (en) | Monoclonal antibodies useful in the identification of microorganisms causing peridontal disease | |
KR910021586A (ko) | 리간드의 면역학적 검출방법 | |
KR910006712A (ko) | 형광편광기술에 사용하기 위한 모노클로날 항체의 안정화 | |
SE8705137D0 (sv) | Diagnostic method for primary biliary cirrhosis and antibodies suitable to be used in certain versions of the method | |
ES8405155A1 (es) | Procedimiento de inmunoanalisis para determinar etosuximida en una muestra de analisis. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8364 | No opposition during term of opposition | ||
8327 | Change in the person/name/address of the patent owner |
Owner name: DADE BEHRING MARBURG GMBH, 35041 MARBURG, DE |
|
8327 | Change in the person/name/address of the patent owner |
Owner name: SIEMENS HEALTHCARE DIAGNOSTICS PRODUCTS GMBH, , DE |